SPOTLIGHT: Drug makers enjoy Q1 success

There's no question that today was a good day for drug makers, as a trio reported bright first quarter numbers. Merck said its net was up significantly and profit rose 11 percent for the quarter. There was reason for celebration at Eli Lilly, where first quarter net was up 13 percent on a doubling in orders for the depressive disorder drug Cymbalta. Article (WSJ sub. req.)